Semarion

Revolutionizing adherent cell assays to unlock better treatments for high unmet clinical needs and enable new research paradigms Semarion has developed a novel class of materials, called SemaCytes®. These micro-scale cell carriers are uniquely engineered with microchip fabrication, nanomagnetism, and smart materials. The core of our innovation lies in turning adherent cells into liquid reagents. Along with features such as assay miniaturization, barcoding, and automation, this facilitates better quality and more reproducible data, while reducing the time and cost to deliver research outputs.